234 related articles for article (PubMed ID: 32571260)
1. Overexpression of HOXA10 is associated with unfavorable prognosis of acute myeloid leukemia.
Guo C; Ju QQ; Zhang CX; Gong M; Li ZL; Gao YY
BMC Cancer; 2020 Jun; 20(1):586. PubMed ID: 32571260
[TBL] [Abstract][Full Text] [Related]
2. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
3. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
[TBL] [Abstract][Full Text] [Related]
4. The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
J Transl Med; 2021 May; 19(1):228. PubMed ID: 34051812
[TBL] [Abstract][Full Text] [Related]
5. High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia.
Li K; Chen L; Zhang H; Wang L; Sha K; Du X; Li D; Zheng Z; Pei R; Lu Y; Tong H
Aging (Albany NY); 2021 Apr; 13(8):11988-12006. PubMed ID: 33891561
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR‑135a predicts poor prognosis in acute myeloid leukemia and regulates leukemia progression via modulating HOXA10 expression.
Xu H; Wen Q
Mol Med Rep; 2018 Jul; 18(1):1134-1140. PubMed ID: 29845297
[TBL] [Abstract][Full Text] [Related]
7. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
[TBL] [Abstract][Full Text] [Related]
8. HoxA10 activates transcription of the gene encoding mitogen-activated protein kinase phosphatase 2 (Mkp2) in myeloid cells.
Wang H; Lu Y; Huang W; Papoutsakis ET; Fuhrken P; Eklund EA
J Biol Chem; 2007 Jun; 282(22):16164-76. PubMed ID: 17430893
[TBL] [Abstract][Full Text] [Related]
9. HoxA10 regulates transcription of the gene encoding transforming growth factor beta2 (TGFbeta2) in myeloid cells.
Shah CA; Wang H; Bei L; Platanias LC; Eklund EA
J Biol Chem; 2011 Jan; 286(4):3161-76. PubMed ID: 21087928
[TBL] [Abstract][Full Text] [Related]
10. HoxA10 influences protein ubiquitination by activating transcription of ARIH2, the gene encoding Triad1.
Wang H; Bei L; Shah CA; Horvath E; Eklund EA
J Biol Chem; 2011 May; 286(19):16832-45. PubMed ID: 21454682
[TBL] [Abstract][Full Text] [Related]
11. A three-gene signature and clinical outcome in pediatric acute myeloid leukemia.
Cai Z; Wu Y; Zhang F; Wu H
Clin Transl Oncol; 2021 Apr; 23(4):866-873. PubMed ID: 32862280
[TBL] [Abstract][Full Text] [Related]
12. HoxA10 activates CDX4 transcription and Cdx4 activates HOXA10 transcription in myeloid cells.
Bei L; Huang W; Wang H; Shah C; Horvath E; Eklund E
J Biol Chem; 2011 May; 286(21):19047-64. PubMed ID: 21471217
[TBL] [Abstract][Full Text] [Related]
13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
14. High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia.
Li J; Ge Z
BMC Cancer; 2021 Apr; 21(1):475. PubMed ID: 33926391
[TBL] [Abstract][Full Text] [Related]
15. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
[TBL] [Abstract][Full Text] [Related]
17. Construction of prognostic risk prediction model based on high-throughput sequencing expression profile data in childhood acute myeloid leukemia.
Niu P; Yao B; Wei L; Zhu H; Fang C; Zhao Y
Blood Cells Mol Dis; 2019 Jul; 77():43-50. PubMed ID: 30954792
[TBL] [Abstract][Full Text] [Related]
18.
Zhang TJ; Zhou JD; Zhang W; Lin J; Ma JC; Wen XM; Yuan Q; Li XX; Xu ZJ; Qian J
Clin Epigenetics; 2018; 10():47. PubMed ID: 29643943
[TBL] [Abstract][Full Text] [Related]
19. LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML.
Ruvolo PP; Hu CW; Qiu Y; Ruvolo VR; Go RL; Hubner SE; Coombes KR; Andreeff M; Qutub AA; Kornblau SM
EBioMedicine; 2019 Jun; 44():126-137. PubMed ID: 31105032
[TBL] [Abstract][Full Text] [Related]
20. HoxA10 protein regulates transcription of gene encoding fibroblast growth factor 2 (FGF2) in myeloid cells.
Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
J Biol Chem; 2012 May; 287(22):18230-48. PubMed ID: 22493287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
